Ticker

No recent analyst price targets found for KOAN.

Latest News for KOAN

Apollo Biowellness Executes Letter Of Intent with Medwell AI, Inc.

North Bergen, New Jersey--(Newsfile Corp. - February 10, 2026) - Apollo Biowellness, Inc. (OTCID: KOAN) (the "Company) is pleased to announce the signing of a Letter of Intent ("LOI") to create a vertically integrated health, wellness and longevity platform. To view an enhanced version of this graphic, please visit: https://images.newsfilecorp.com/files/10533/283349_a912020384f54aed_001full.jpg New MedWell Ai, Inc…

Newsfile Corp • Feb 10, 2026
Apollo Biowellness, Inc., Announces Termination of Distribution Agreement with Revive Regenerative, Inc.

North Bergen, New Jersey--(Newsfile Corp. - February 6, 2026) - Apollo Biowellness, Inc. (OTCID: KOAN) (the "Company), announces that the 'Exclusive Distribution Agreement' dated July 1, 2025, between Evolutionary Biologics (a wholly owned subsidiary of Apollo Biowellness) and Revive Regenerative, Inc. ("Revive") has been "terminated for cause" by Evolutionary Biologics, for reasons already disclosed to Revive…

Newsfile Corp • Feb 6, 2026
Apollo Biowellness, Inc., Announces Expiration of Letter of Intent, Negotiations Continue

North Bergen, New Jersey--(Newsfile Corp. - January 7, 2026) - Apollo Biowellness, Inc. (OTCID: KOAN) (the "Company"), announces that the Letter of Intent between the Company and Revive Regenerative, Inc., dated September 12, 2025, (the "LOI") has expired and it no longer in effect. To view an enhanced version of this graphic, please visit:…

Newsfile Corp • Jan 7, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for KOAN.

No House trades found for KOAN.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top